Generic Name: Eribulin (er i BUE lin)
Trade Name(s): Halaven ®
Eribulin is the generic name for the trade name drug Halaven. In some cases, health care professionals may use the trade name Halaven when referring to the generic drug name eribulin.
Halaven is an anti-cancer (antineoplastic or cytotoxic) chemotherapy drug. This medication is classified as a non-taxane microtubule inhibitor. (For more detail, see How Halaven Works below)
What Halaven Is Used For:
Halaven is used for the treatment of patients with metastatic breast cancer.
Note: If a drug has been approved for one use, physicians may elect to use this same drug for other problems if they believe it may be helpful.
How Halaven Is Given:
The amount of Halaven that you will receive depends on many factors, including your height and weight, your general health or other health problems, and the type of cancer or condition you have. Your doctor will determine your exact dosage and schedule.
Side effects of Halaven:
Important things to remember about the side effects of Halaven:
The following side effects are common (occurring in greater than 30%) for patients taking Halaven:
These are less common (occurring in 10-29%) side effects for patients receiving Halaven: